OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...
AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...
AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback